A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension

NCT05167825 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Macitentan

Sponsor

Janssen Pharmaceutical K.K.